Kalaris Therapeutics (KLRS) Change in Accured Expenses (2019 - 2026)
Kalaris Therapeutics (KLRS) posted Change in Accured Expenses of $747,000 for Q2 2026, compared with -$797,000 a year earlier and up 522.5% from the prior quarter.
Powered by 
Analysis
Kalaris Therapeutics (KLRS) Change in Accured Expenses (2019 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Change in Accured Expenses at Kalaris Therapeutics was $3.82 million; for FY2025, it came in at $2.14 million.
- Annual Change in Accured Expenses shows a five-year compound annual growth rate of -4.7% (FY2020 to FY2025).
- In prior years, Kalaris Therapeutics' Change in Accured Expenses was $115,000 in FY2024, -$2.51 million in FY2023, -$12.62 million in FY2022 and $20.29 million in FY2021 (+644.3%).
- Quarterly Change in Accured Expenses has run from a low of -$13.79 million in Q1 2022 to a high of $11.48 million in Q4 2021 over five years.
- According to Business Quant data, Change in Accured Expenses for the three prior quarters was $120,000 (Q1 2026), $1.73 million (Q4 2025) and $1.22 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 2.96 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 1.20 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -251.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 901.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 338.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Kalaris Therapeutics | 64.27 Mn | 64.27 Mn | - | 747,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 747,000.00 |
| Mar 31, 2026 | 120,000.00 |
| Dec 31, 2025 | 1.73 Mn |
| Sep 30, 2025 | 1.22 Mn |
| Jun 30, 2025 | -797,000.00 |
| Mar 31, 2025 | -8,000.00 |
| Dec 31, 2024 | 665,000.00 |
| Sep 30, 2024 | -329,000.00 |
| Jun 30, 2024 | 57,000.00 |
| Mar 31, 2024 | -278,000.00 |
| Dec 31, 2023 | -5.56 Mn |
| Sep 30, 2023 | -1.86 Mn |
| Jun 30, 2023 | 5.39 Mn |
| Mar 31, 2023 | -486,000.00 |
| Dec 31, 2022 | -1.74 Mn |
| Sep 30, 2022 | -521,000.00 |
| Jun 30, 2022 | 3.42 Mn |
| Mar 31, 2022 | -13.79 Mn |
| Dec 31, 2021 | 11.48 Mn |
| Sep 30, 2021 | 2.09 Mn |
API Access
Kalaris Therapeutics Change in Accured Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=KLRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "KLRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=KLRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();